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In this issue of Molecular Cell, Cheverton et al. (2016) report that Samonella toxin TacT contributes to
persister formation by acetylating tRNA, a novel mechanism of toxin action. Hydrolyzing corrupted tRNA re-
suscitates persisters.Persisters are dormant variants that form
a subpopulation of cells tolerant to antibi-
otics (Lewis, 2010). Persisters are largely
responsible for recalcitrance of chronic
infections. Knowing the molecular mech-
anism of persister formation is important
for developing treatments that can kill
persisters. In this issue of Molecular Cell,
Cheverton et al. (2016) reported a novel
molecular mechanism of persister forma-
tion as well as resuscitation.
Most of what we know about the mech-
anism of persister formation comes from
the study of E. coli, and toxin-antitoxin
(TA) modules have been linked to
persister formation. Isolated persisters
express high levels of interferases—
mRNA-degrading toxins and their associ-
ated antitoxins. Ectopic expression of
toxins causes multidrug tolerance (Keren
et al., 2004). In E. coli, deleting single
interferases does not produce a pheno-Figure 1. A Novel Molecular Mechanism of Samonella Persister
Formation and Resuscitation
Samonella toxin TacT acetylates aminoacyl-tRNA to inhibit translation. The
action of the toxin may explain the increase in persisters in Samonella upon
entry into macrophages. The hydrolase Pth cleaves off the acetylated ami-
noacyl-releasing free tRNA, translation resumes, and persisters wake up.type, but the level of per-
sisters was reported to be
decreased in a strain deleted
in 10 TA interferases (D10TA)
(Maisonneuve et al., 2013).
Single deletion of a toxin
may affect persister forma-
tion during stresses. One
example is TisB, a toxin that
is induced during DNA dam-
age and forms an ion channel
in the cytoplasmic mem-
brane, decreasing the proton
motive force and ATP, leading
to drug tolerance (Do¨rr et al.,
2010). Gain-of-functionmuta-
tions in another toxin, hipA,
which inhibits protein synthe-
sis by phosphorylating glu-
tRNA synthetase (Germain
et al., 2013; Kaspy et al.,
2013), produces elevated
levels of persisters in vitro.The same mutants are present in patients
with relapsing urinary tract infections
(UTIs), showing that toxins play an impor-
tant role in the recalcitrance of chronic in-
fections to antibiotics (Schumacher et al.,
2015).
In a previous study, the same group re-
ported that persister levels dramatically
increase when Salmonella enters macro-
phages. Interestingly, deletion of individ-
ual toxins then sharply decreased
persister levels in macrophages. One of
these toxins is TacT, whose mechanism
of action was unknown (Helaine et al.,
2014). Here, Cheverton et al. (2016) deci-
pher the molecular mechanism of TacT
and provide an important insight into
persister resuscitation.
Overexpression of tacT in exponential
phase had no effect on Salmonella
growth. However, early overexpression
of tacT extends the lag phase. To iden-Moleculartify the target of TacT, the effect of over-
expressing the toxin on label incorpora-
tion into DNA, RNA, or protein was
tested. Only protein synthesis was
inhibited.
TacT has homology to known acetyl-
transferases, pointing to its possible
mechanism of action. Mutations in either
the predicted acetyl-CoA binding site or
acceptor transfer site completely abol-
ished toxicity of TacT, and deletion of de-
acetylase CobB lead to toxicity of TacT in
exponential phase.
To further pinpoint the target, purified
TacT was introduced into an in vitro trans-
lation system and was found to acetylate
aminoacyl-tRNA but not peptidyl-tRNA.
A structural study then revealed that
tRNA binds to the TacT dimer by electro-
static interactions, and TacT acetylates
the primary amine group of the amino
acid on the charged tRNA to prevent theCell 63, Julyformation of the peptide
bond. This is the first report
of a toxin that acts by
acetylation of charged tRNA
(Figure 1).
To better understand
growth resumption of per-
sisters, the authors conduct-
ed a screen for genes that
suppress toxicity of TacT.
They found that overex-
pression of peptidyl-tRNA
hydrolase Pth counteracts
the toxicity of TacT as well
as TacT-induced persister
formation, and an in vitro
study revealed that Pth
hydrolyzes acetylated ami-
noacyl-tRNA and releases
uncharged tRNA. This
shows that Pth has enzy-
matic activity against not
only peptidyl-tRNA but also7, 2016 ª 2016 Elsevier Inc. 3
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Previewsacetylated aminoacyl-tRNA and may
function as a mechanism for persister
resuscitation.
This study is the first step toward un-
derstanding the physiological roles of
this unusually interesting toxin and
many important questions remain to be
answered: Why does TacT only exhibit
toxicity in lag phase—do exponentially
growing cells have high deacetylase
or hydrolase activity? But then why
does a knockout of TacT fail to form
persisters when S. typhimurium infects
macrophages?
It is notable that although TacT is the
only known toxin that acetylates
charged tRNA, the translation process
seems to be a target of choice for
many unrelated toxins. For example,
mRNA interferases inhibit translation
by depleting cellular mRNA pool, and
HipA inhibits translation by phosphory-
lating glu-tRNA synthesase. Interest-4 Molecular Cell 63, July 7, 2016 ª 2016 Elseingly, this mirrors the well-known prefer-
ence of antibiotics—dozens of unrelated
compounds target the highly conserved
translation machinery. Bacteriostatic
inhibitors of translation, chloramphen-
icol, or erythromycin cause tolerance
to other antibiotics, emulating persister
formation. Washing away antibiotics
restores growth and susceptibility,
but how persisters resuscitate from
dormancy caused by toxins has been
puzzling. Indeed, if a toxin inhibits
translation, it would be difficult for a
cell to counter its action by synthe-
sizing an antitoxin. This problem is
removed in the case of TacT, where its
target can be deacetylated by an exist-
ing enzyme such that the detoxification
process does not require protein syn-
thesis. Thanks to the study of Cheverton
and co-authors, we now have the first
example of solving the puzzle of persister
resuscitation.vier Inc.REFERENCES
Cheverton, A.M., Gollan, B., Przydacz, M., Wong,
C.T., Mylona, A., Hare, S.A., and Helaine, S.
(2016). Mol. Cell 63, this issue, 86–96.
Do¨rr, T., Vulic, M., and Lewis, K. (2010). PLoS Biol.
8, e1000317.
Germain, E., Castro-Roa, D., Zenkin, N., and
Gerdes, K. (2013). Mol. Cell 52, 248–254.
Helaine, S., Cheverton, A.M., Watson, K.G., Faure,
L.M., Matthews, S.A., and Holden, D.W. (2014).
Science 343, 204–208.
Kaspy, I., Rotem, E., Weiss, N., Ronin, I., Balaban,
N.Q., andGlaser, G. (2013). Nat. Commun. 4, 3001.
Keren, I., Shah, D., Spoering, A., Kaldalu, N., and
Lewis, K. (2004). J. Bacteriol. 186, 8172–8180.
Lewis, K. (2010). Annu. Rev. Microbiol. 64,
357–372.
Maisonneuve, E., Castro-Camargo, M., and
Gerdes, K. (2013). Cell 154, 1140–1150.
Schumacher, M.A., Balani, P., Min, J., Chinnam,
N.B., Hansen, S., Vulic, M., Lewis, K., and
Brennan, R.G. (2015). Nature 524, 59–64.Length Matters: MINDY Is a New
Deubiquitinase Family that Preferentially Cleaves
Long Polyubiquitin ChainsTill Maurer1 and Ingrid E. Wertz2,3,*
1Department of Structural Biology
2Departmant of Discovery Oncology
3Department of Early Discovery Biochemistry
Genentech Inc., 1 DNA Way, South San Francisco, CA, 94080, USA
*Correspondence: wertz.ingrid@gene.com
http://dx.doi.org/10.1016/j.molcel.2016.06.027
Abdul Rehman and colleagues identify a sixth family of deubiquitinase enzymes that are highly conserved
throughout eukaryotes and show a remarkable selectivity for cleaving extended Lys-48-linked polyubiquitin
chains.The ubiquitin system orchestrates protein
degradation and signal transduction and,
as such, is essential for maintaining
cellular homeostasis. Ubiquitination de-
scribes the covalent ligation of the 76-aa
protein ubiquitin to substrates and is remi-
niscent of glycosylation, in that both chain
length and the linkage type dictate signal
readout. For example, lysine-48 (K48)-
linked ubiquitin chains commonly tagsubstrates for proteasomal degradation,
whereas K63-linked chains may serve as
molecular scaffolds to enhance signal
transduction (Komander and Rape,
2012). Ubiquitin ligases are the arbiters
of selective substrate ubiquitination,
whereas deubiquitinases reverse this pro-
cess. Approximately 100 deubiquitinases
have been identified in the human
genome and are classified into five fam-ilies based on the architecture of their
catalytic domains: ubiquitin-specific pro-
teases (termed USPs), ovarian tumor pro-
teases (OTUs), ubiquitin carboxy-terminal
hydrolases (UCHs), the Machado-Joseph
disease proteases (MJDs), and zinc-
dependent metalloproteases (JAMMs).
Deubiquitinases may contain additional
domains that facilitate substrate binding,
cofactor association, and otherwise
